Extreme Heat Correlates with Higher Infant Mortality in Sub-Saharan Africa
A recent study reveals that rising temperatures significantly increase neonatal mortality in Sub-Saharan Africa, emphasizing the need for targeted interventions to protect vulnerable populations amid climate change.
Recent research highlights a alarming link between rising temperatures and infant mortality rates in Sub-Saharan Africa, which already bears the world’s highest infant mortality rate, with 27 out of every 1,000 newborns dying within their first month. The study underscores that increasing heat exposure during pregnancy can adversely impact fetal development, as extreme temperatures may reduce placental blood flow and cause dehydration, potentially leading to fetal harm. Additionally, such heat conditions can promote the growth of harmful bacteria and pose challenges for pregnant women to access essential prenatal care.
The study, conducted by Jiafu An and colleagues, analyzed 883,623 birth records from 33 African nations spanning 2006 to 2022, correlating birth outcomes with local climate data. Results indicate that an extra 50 days of exposure to extreme heat during pregnancy is associated with an increase of 1 to 4 neonatal deaths per 1,000 live births, primarily affecting rural areas. The data also show that socio-economic disadvantages amplify this risk, with less educated and financially constrained mothers experiencing more severe impacts. The researchers advocate for targeted interventions, including community health support, infrastructure improvements in education and electricity, and broader economic development to safeguard vulnerable women and improve neonatal outcomes.
This important study emphasizes the urgent need to address climate-related health risks and reinforce maternal and infant healthcare infrastructure in vulnerable regions, especially as global temperatures continue to rise.
Source: https://medicalxpress.com/news/2025-08-extreme-infant-mortality-saharan-africa.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Effective Use of Common Autoimmune Medicine for Treating Giant Cell Arteritis
A groundbreaking clinical trial demonstrates that the autoimmune drug upadacitinib can induce remission in giant cell arteritis, reducing reliance on steroids and improving patient outcomes.
Genetic Mechanism Behind Leukemia Cells' Resistance to Chemotherapy Discovered
A groundbreaking study uncovers how a genetic switch involving RUNX1C helps leukemia cells hide from chemotherapy, opening new possibilities for targeted treatments to prevent relapse and improve patient outcomes.
New Clinical Trial Demonstrates Potential of Vitamin B3 Derivative in Managing Premature Aging Disorder
A pioneering clinical trial demonstrates that nicotinamide riboside, a Vitamin B3 derivative, can improve health markers and reduce complications in patients with Werner syndrome, a rare premature aging disorder.
Common Anti-Inflammatory Medication May Reduce Blood Mutations Linked to Heart Disease
Low-dose colchicine may slow the growth of harmful blood cell mutations linked to increased risk of heart disease and blood cancers, offering new potential for cardiovascular risk management.